Plenty of winners could be found this week among health-care stocks. Unfortunately for some shareholders, these three weren't among those winners.

One of the week's big losers felt the sting of a delay by the U.S. Food and Drug Administration. Another reported poor financial results, although those results likely caught few by surprise. The third horrendous performer got slammed by speculation that the company could announce bad news soon.

Which three health-care stocks were utterly crushed by the market this week? Find out by watching the slideshow below.


Leaked: This coming blockbuster will make every biotech jealous
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need to Motley Fool’s new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

Keith Speights has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.